Cold turkey might feel bold, while gradual reduction feels practical, but both lead to the same destination: a healthier, tobacco-free you
While injectable GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have transformed the treatment landscape for obesity and type 2 diabetes, their reliance on subcutaneous injection remains a significant barrier to broader adoption
Common requirements include documented BMI meeting the threshold, proof of previous weight loss attempts (usually 3-6 months of supervised diet and exercise), at least one qualifying comorbidity, and sometimes evidence that other treatments have been tried and failed
Clinical data on GH-deficient adults consistently show thinner, less elastic skin as a feature of deficiency, with improvements in skin thickness and collagen density following GH replacement